Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 18.4617.0718.1918.4518.09

What is the latest Core EBITDA Margin ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of BALAXI PHARMACEUTICALS is 18.46 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202418.46
Mar202317.07
Mar202218.19
Mar202118.45
Mar202018.09

How is Core EBITDA Margin of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 18.46
8.14
Mar2023 17.07
-6.16
Mar2022 18.19
-1.41
Mar2021 18.45
1.99
Mar2020 18.09 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹384.0 Cr -1.9% -3.6% -20.8% Stock Analytics
ADANI ENTERPRISES ₹269,905.0 Cr 3.4% -1.5% -28.4% Stock Analytics
REDINGTON ₹18,117.6 Cr 13.8% 13.6% 17.9% Stock Analytics
MMTC ₹10,006.5 Cr 0.6% -5% -28.7% Stock Analytics
HONASA CONSUMER ₹6,959.4 Cr -4.6% -11.4% -48.8% Stock Analytics
MSTC ₹4,068.4 Cr -0.6% -8.4% -46.3% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.9%

-3.6%

-20.8%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses